Juul Labs has received authorization from the US Food and Drug Administration to keep selling its e-cigarettes, including its original device and tabacco and methol refill pods, The Wall Street Journal reported Thursday, citing people familiar with the matter.
The decision comes five years after Juul first submitted its products for federal review, the report said.
The approval marks a key turnaround for the company, which was nearly pushed into bankruptcy after the FDA ordered a sales ban in 2022 due to unresolved concerns about its toxicology data. Although that ban was quickly put on hold, it triggered a financial crisis and waves of lawsuits, according to the report.
Juul Labs and the FDA didn't immediately reply to MT Newswires' requests for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 58.02, Change: -0.84, Percent Change: -1.44
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.